Building a premier biotech hub in Birmingham Station 41 is a “great stride” toward a new center of commercialization Story by Matt Windsor | Photos by.
AeroNeph Therapeutics (“AeroNeph”; www.aeronephtx.com), a pioneer in discovery of renal disease assets, has announced its MBO and corporate launch in the USA.